
Sign up to save your podcasts
Or


Today, an in-depth look at puberty blockers and their use on minors with gender dysphoria. These drugs have come under an enormous amount of scrutiny in recent years, with some questioning their benefits, safety and long-term impact.
After banning the use of puberty blockers for gender treatment of people under 18, a new clinical trial in the U.K. aims to get to the bottom of those concerns.
Azeen Ghorayshi is a science and gender reporter for the New York Times.
She’ll parse through what we know and don’t know about the effects of blockers in minors, how this became a hugely divisive and politicized debate around the world, and whether this new trial could change our understanding.
For transcripts of Front Burner, please visit: https://www.cbc.ca/radio/frontburner/transcripts
By CBC3.9
217217 ratings
Today, an in-depth look at puberty blockers and their use on minors with gender dysphoria. These drugs have come under an enormous amount of scrutiny in recent years, with some questioning their benefits, safety and long-term impact.
After banning the use of puberty blockers for gender treatment of people under 18, a new clinical trial in the U.K. aims to get to the bottom of those concerns.
Azeen Ghorayshi is a science and gender reporter for the New York Times.
She’ll parse through what we know and don’t know about the effects of blockers in minors, how this became a hugely divisive and politicized debate around the world, and whether this new trial could change our understanding.
For transcripts of Front Burner, please visit: https://www.cbc.ca/radio/frontburner/transcripts

419 Listeners

362 Listeners

109 Listeners

141 Listeners

226 Listeners

211 Listeners

206 Listeners

68 Listeners

66 Listeners

92 Listeners

91 Listeners

29 Listeners

209 Listeners

93 Listeners

24 Listeners

107 Listeners

266 Listeners

21 Listeners

14 Listeners